by University of Technology, Sydney Credit: Pixabay/CC0 Public Domain Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD)—the targeting and inhibition of a protein called RIPK1. The third leading cause of death worldwide and with no...
